What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His primary scientific interests are in Prostate cancer, Prostate, Prostatectomy, Prostate-specific antigen and Urology.
His work deals with themes such as Biopsy, Gynecology and Oncology, which intersect with Prostate cancer.
His Prostate research incorporates elements of Immunohistochemistry, Hyperplasia, Pathology and Antigen.
His studies deal with areas such as Stage, Surgery and Adenocarcinoma as well as Prostatectomy.
The Prostate-specific antigen study which covers Radiation therapy that intersects with Hormonal therapy.
His research investigates the connection with Urology and areas like Confidence interval which intersect with concerns in Area under the curve.
His most cited work include:
- Natural history of progression after PSA elevation following radical prostatectomy. (2543 citations)
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: A multi- institutional update (1687 citations)
- The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer (1123 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Prostate cancer, Internal medicine, Prostatectomy, Prostate and Urology.
His Prostate cancer study focuses on Prostate-specific antigen in particular.
His research in Internal medicine tackles topics such as Oncology which are related to areas like Retrospective cohort study.
His biological study spans a wide range of topics, including Metastasis, Surgery and Cohort.
His study in Prostate is interdisciplinary in nature, drawing from both Adenocarcinoma and Pathology.
He has included themes like Pathological, Survival rate, Lymph node, Prospective cohort study and Hyperplasia in his Urology study.
He most often published in these fields:
- Prostate cancer (63.30%)
- Internal medicine (42.09%)
- Prostatectomy (41.86%)
What were the highlights of his more recent work (between 2013-2021)?
- Prostate cancer (63.30%)
- Internal medicine (42.09%)
- Oncology (32.80%)
In recent papers he was focusing on the following fields of study:
Alan W. Partin focuses on Prostate cancer, Internal medicine, Oncology, Prostatectomy and Prostate.
His research in Prostate cancer is mostly focused on Prostate-specific antigen.
His study in the field of Urine, Disease and Adverse effect also crosses realms of In patient and Risk assessment.
His Oncology research includes elements of Clinical endpoint and GSTP1.
The various areas that Alan W. Partin examines in his Prostatectomy study include Surgery, Proportional hazards model, Metastasis and Urology.
His work carried out in the field of Prostate brings together such families of science as Prospective cohort study, Overdiagnosis and Pathology.
Between 2013 and 2021, his most popular works were:
- A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer (301 citations)
- A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy (238 citations)
- Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer (154 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Alan W. Partin mainly focuses on Prostate cancer, Internal medicine, Prostatectomy, Prostate and Oncology.
His Prostate cancer research is multidisciplinary, incorporating elements of Biopsy and Gynecology.
His Biopsy research includes themes of Prostate cancer screening and Urology.
His studies deal with areas such as Gastroenterology and Ex vivo as well as Internal medicine.
Alan W. Partin has included themes like Surgery, Proportional hazards model, Cohort and Hazard ratio in his Prostatectomy study.
His Prostate study combines topics in areas such as Prospective cohort study, Overdiagnosis, Pathology and Cell therapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
